Veracyte, Inc.

VCYT

$49.24

Name : Veracyte, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $3,928,990,208.00

EPSttm : 1.08

Veracyte, Inc.

$49.24

4.17%

$1.97

VCYT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.06

Margin Of Safety %

-29

Put/Call OI Ratio

0.3

EPS Next Q Diff

-0.09

EPS Last/This Y

0.98

EPS This/Next Y

0.08

Price

49.24

Target Price

49.1

Analyst Recom

1.55

Performance Q

50.21

Upside

-71.2%

Beta

1.96

Ticker: VCYT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	VCYT	39.7	0.18	0.00	3644
2026-05-12	VCYT	39.53	0.18	0.09	3659
2026-05-13	VCYT	38.26	0.18	0.00	3655
2026-05-14	VCYT	38.87	0.18	0.00	3658
2026-05-15	VCYT	38.48	0.18	0.00	3658
2026-05-18	VCYT	41.5	0.16	0.00	3018
2026-05-19	VCYT	41.69	0.16	0.30	3046
2026-05-20	VCYT	45.21	0.17	0.12	3106
2026-05-21	VCYT	45.21	0.16	0.37	3312
2026-05-22	VCYT	45.21	0.16	0.46	3301
2026-05-26	VCYT	44.23	0.16	1.73	3318
2026-05-27	VCYT	44.49	0.19	0.03	3442
2026-05-28	VCYT	48.02	0.19	0.13	3462
2026-05-29	VCYT	46.34	0.19	0.00	3489
2026-06-02	VCYT	47.84	0.18	0.10	3631
2026-06-03	VCYT	48.71	0.18	0.07	3759
2026-06-04	VCYT	49.93	0.18	0.06	3811
2026-06-05	VCYT	48.73	0.18	0.06	3804
2026-06-08	VCYT	47.28	0.18	4.71	3808
2026-06-09	VCYT	49.21	0.30	0.00	4144
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	VCYT	39.69	-1.0	-28.5	1.82
2026-05-12	VCYT	39.55	-1.5	-8.5	1.83
2026-05-13	VCYT	38.26	-1.5	-11.2	1.83
2026-05-14	VCYT	38.89	-1.5	-6.6	1.83
2026-05-15	VCYT	38.47	-1.5	-9.2	1.83
2026-05-18	VCYT	41.48	-1.1	-0.8	1.82
2026-05-19	VCYT	41.69	-1.1	-7.7	1.82
2026-05-20	VCYT	45.21	-1.1	-0.2	1.82
2026-05-21	VCYT	45.18	-1.1	-8.1	1.82
2026-05-22	VCYT	45.04	-1.1	-8.5	1.82
2026-05-26	VCYT	44.21	-1.1	-9.8	1.82
2026-05-27	VCYT	44.51	-1.1	-7.6	1.82
2026-05-28	VCYT	47.99	-1.1	-0.8	1.82
2026-05-29	VCYT	46.33	-1.1	-11.4	1.82
2026-06-01	VCYT	48.16	-1.1	-4.5	1.82
2026-06-02	VCYT	47.61	-1.1	-9.2	1.82
2026-06-03	VCYT	48.70	-1.1	-6.4	1.82
2026-06-04	VCYT	49.98	-1.1	-5.7	1.82
2026-06-05	VCYT	48.74	-1.6	-10.4	1.82
2026-06-08	VCYT	47.29	-1.6	-10.9	1.82
2026-06-09	VCYT	49.24	-1.6	-4.3	1.82
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	VCYT	-8.60	0.45	8.28
2026-05-12	VCYT	-8.60	0.45	8.82
2026-05-13	VCYT	-8.11	0.45	8.82
2026-05-14	VCYT	-8.11	0.45	8.82
2026-05-15	VCYT	-8.11	0.45	8.82
2026-05-18	VCYT	-8.11	0.43	8.82
2026-05-19	VCYT	-7.96	0.43	8.82
2026-05-20	VCYT	-7.96	0.43	8.82
2026-05-21	VCYT	-7.96	0.43	8.82
2026-05-22	VCYT	-7.52	0.43	8.82
2026-05-26	VCYT	-7.96	3.85	8.84
2026-05-27	VCYT	-7.29	3.85	8.84
2026-05-28	VCYT	-8.27	3.85	11.05
2026-05-29	VCYT	-8.27	3.85	11.05
2026-06-02	VCYT	-8.27	3.13	11.05
2026-06-03	VCYT	-8.27	3.13	11.05
2026-06-04	VCYT	-8.27	3.13	11.05
2026-06-05	VCYT	-13.42	3.13	11.05
2026-06-08	VCYT	-13.42	3.07	11.06
2026-06-09	VCYT	-12.53	3.07	11.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.52

Avg. EPS Est. Current Quarter

0.43

Avg. EPS Est. Next Quarter

0.43

Insider Transactions

-12.53

Institutional Transactions

3.07

Beta

1.96

Average Sales Estimate Current Quarter

144

Average Sales Estimate Next Quarter

148

Fair Value

34.82

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-71.5

Target Price

49.1

P/E

45.33

Forward P/E

25.94

PEG

6.9

P/S

7.25

P/B

2.92

P/Free Cash Flow

25.29

EPS

1.09

Average EPS Est. Cur. Y

1.82

EPS Next Y. (Est.)

1.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.25

Relative Volume

0.98

Return on Equity vs Sector %

-20.9

Return on Equity vs Industry %

-4.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.17

EBIT Estimation

-4.3

◆ VCYT Healthcare

$49.24

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

4/25

Volume

7/15

Valuation

3/20

TP/AR

1/10

Options

7/10

RSI

67.1

Range 1M

80.4%

Sup Dist

5.8%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

13/25

Growth

15/30

Estimates

5/20

Inst/Vol

9/15

Options

8/10

EPS Yr

2.7%

EPS NY

3.8%

52W%

90.4%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -33.8% upside

Quality

16/30

Valuation

1/30

Growth

10/25

Stability

8/10

LT Trend

1/5

Upside

-33.8%

Quality

MoS

-29%

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 755

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

VCYT

Latest News

—

Caricamento notizie per VCYT…

stock quote shares VCYT – Veracyte, Inc. Stock Price stock today

news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte, Inc. yahoo finance google finance

stock history VCYT – Veracyte, Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y